Education
About Us
Working with TipRanks
Follow Us
ImExHS Limited (AU:IME)
ASX:IME
IME Stock Chart & Stats
AU$0.40
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.40
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.22 - AU$0.47
Previous CloseN/A
Volume202.98K
Average Volume (3M)41.77K
Market Cap
AU$21.89M
Enterprise ValueAU$18.89M
Total Cash (Recent Filing)AU$3.30M
Total Debt (Recent Filing)AU$566.32K
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding54,050,686
10 Day Avg. Volume23,052
30 Day Avg. Volume41,775
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)1.29
Price to Sales (P/S)0.71
P/FCF Ratio83.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.50Price Target Upside25.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.03
Revenue Forecast (FY)AU$31.00M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthMaterial multi-year revenue scaling demonstrates durable market demand and successful customer adoption of the company's offerings. A larger revenue base supports investments in product development, sales scale and fixed-cost absorption, improving the firm's ability to achieve sustainable profitability over the medium term.
Positive Operating PerformanceThe shift to positive EBITDA and margin expansion signals improved operational leverage and cost discipline. Consistent positive operating cash generation potential from EBITDA provides a pathway to cover capex and reinvestment, reducing reliance on external funding if maintained.
Conservative Balance SheetVery low leverage and sizeable equity relative to assets give financial flexibility to fund growth, absorb shocks, and delay or minimize dilutive capital raises. A conservative capital structure lowers refinancing and interest rate risk, supporting long-term strategic investments.
Bears Say
Persistent Net LossesOngoing net losses and negative returns on equity indicate the company has yet to convert top-line growth into shareholder returns. Continued losses can erode equity, constrain reinvestment capacity, and create dependence on external financing, raising structural execution and solvency risk if not reversed.
Volatile/Gross Margin DeclineA sharp year-over-year gross margin decline points to adverse mix, pricing pressure, or rising direct costs. If persistent, weaker unit economics can undermine the path from revenue growth to sustainable profitability and reduce the effectiveness of operating leverage.
Inconsistent Cash GenerationIrregular operating and free cash flow history increases funding uncertainty for operations and strategic initiatives. Even with recent positive cash flow, the multi-year volatility raises the risk that the firm will need periodic external capital, which could dilute shareholders or constrain growth options.
ImExHS Limited News
IME FAQ
What was ImExHS Limited’s price range in the past 12 months?
ImExHS Limited lowest share price was AU$0.22 and its highest was AU$0.47 in the past 12 months.
What is ImExHS Limited’s market cap?
ImExHS Limited’s market cap is AU$21.89M.
When is ImExHS Limited’s upcoming earnings report date?
ImExHS Limited’s upcoming earnings report date is Aug 31, 2026 which is in 177 days.
How were ImExHS Limited’s earnings last quarter?
ImExHS Limited released its earnings results on Feb 26, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of -AU$0.015 by AU$0.017.
Is ImExHS Limited overvalued?
According to Wall Street analysts ImExHS Limited’s price is currently Undervalued.
Does ImExHS Limited pay dividends?
ImExHS Limited does not currently pay dividends.
What is ImExHS Limited’s EPS estimate?
ImExHS Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImExHS Limited have?
ImExHS Limited has 54,050,686 shares outstanding.
What happened to ImExHS Limited’s price movement after its last earnings report?
ImExHS Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of -AU$0.015. Following the earnings report the stock price went up 9.756%.
Which hedge fund is a major shareholder of ImExHS Limited?
Currently, no hedge funds are holding shares in AU:IME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ImExHS Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.50 (25.00% Upside)
AU$0.50 (25.00% Upside)
Blogger Sentiment
Bullish
AU:IME Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.55%
12-Months-Change
Fundamentals
Return on Equity
-27.84%
Trailing 12-Months
Asset Growth
4.43%
Trailing 12-Months
Company Description
ImExHS Limited
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA.I, a set of artificial intelligence tools in the cloud that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. The company was incorporated in 2001 and is based in Mascot, Australia.
IME Stock 12 Month Forecast
Average Price Target
AU$0.50
▲(25.00% Upside)
Technical Analysis
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---